Gilead's Remdesivir Touted as Possibly Effective by the WHO

Remdesivir was touted yesterday as possibly effective against COVID-19 by the WHO. As a result of the announcement, the market increased its interest in Gilead Sciences' product, being one of the lone stocks winning market capitalization. Additionally, the results of clinical trials with remdesivir will be available within weeks, possibly in April.

The other pharmaceutical company rising as of Tuesday is Moderna, which announced the shipment of potential vaccines for human testing.